Conditions & Recovery · STAT News · October 6, 2026

Opinion: Why the FDA should not approve an ineffective multicancer screening test

“Telling more people they have cancer is not progress; progress is having fewer people die from cancer,” H. Gilbert Welch writes of Grail’s multicancer screening test.

Originally published by STAT News. We curate and add context; they did the reporting.

Read the full story at STAT News ↗

Related learning

Biotech Firm Claims Some Credit for Groundbreaking Virus Research Biotech Firm Claims Some Credit for Groundbreaking Virus Research James P. Allison, Ph.D., bangs gong after completing proton therapy treatment Combination therapy helps plasmacytoid bladder cancer survivor